Category: Uncategorized

NAXS Year-end Report 2020

January-December 2020 Net profit for the year amounted to MSEK 24.1 (37.1). Earnings per share amounted to SEK 2.16 (3.24). Net asset value amounted to MSEK 679 (SEK 60.87 per share) at December 31, 2020, compared to MSEK 710 (SEK 63.63 per share) at December 31, 2019. Net cash amounted to MSEK 219 (SEK 19.65 […] Read more

28 January 2021

Nordic Capital and Astorg invest in pharmaceutical technology and advanced analytics company

Cytel is one of the leading global providers of clinical trial design technology, biometric services and advanced analytics, focusing on optimizing clinical trials and helping pharmaceutical companies to unlock the full potential of their clinical and real-world data Nordic Capital and Astorg will actively support and accelerate Cytel’s next phase of growth and innovation, drawing on their extensive experience of investing in healthcare and technologyRead more

21 December 2020

Nordic Capital Fund X acquires RegTech

Nordic Capital has signed an agreement with management and technology consulting firm BearingPoint to acquire BearingPoint RegTech (“RegTech” or the “Company”), a leading European provider of unique software solutions across the regulatory value chain. Nordic Capital intends to support RegTech’s next phase of innovation and sustainable growth by investing in the Company’s continued product development, enhancing its organisational capacity and expanding its international footprint. Read more

4 November 2020

NAXS Interim report January-September 2020

Nine months 2020 Net profit for the interim period amounted to MSEK -6.0 (26.4). Earnings per share amounted to SEK -0.54 (2.29). Net asset value amounted to MSEK 676 (SEK 60.58 per share) at September 30, 2020, compared to MSEK 710 (SEK 63.63 per share) at December 31, 2019. Net cash amounted to MSEK 215 […] Read more

20 October 2020